EU's New Patent Waiver Boosts Jab Access In Emergencies
The European Commission adopted new rules Tuesday ensuring that emergency products like vaccines are immediately available during a crisis despite being subject to patent protections and other IP mechanisms....To view the full article, register now.
Already a subscriber? Click here to view full article